How many studies have been conducted on Cyclophosphamide?

BiohacksAI has indexed 297 PubMed studies on Cyclophosphamide, including 4 randomized controlled trials (RCTs). 17% of studies involve human subjects.

What are the main research areas for Cyclophosphamide?

The primary research domains for Cyclophosphamide are 🔬 Oncology, 🛡️ Immunity, 🫘 Kidney. This is based on analysis of 297 PubMed studies using the BiohacksAI evidence platform.

BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.

Cyclophosphamide

an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the LIVER to form the active aldophosphamide. It has been used in the treatment of LYMPHOMA and LEUKEMIA. Its side effect, ALOPECIA, has been used for defleecing sheep. Cyclophosphamide may also cause sterility, birth defects, mutations, and cancer.

297+ PubMed studies analyzed · 4 RCTs · Evidence Score: 40.1

Research Domains

Cyclophosphamide has been studied across 12 research domains including 🔬 Oncology, 🛡️ Immunity, 🫘 Kidney, 🫁 Liver & Detox, ✨ Skin & Hair. The primary research focus is 🔬 Oncology with 24% of studies addressing this area.

Loading evidence profile...

This evidence profile for Cyclophosphamide is generated deterministically from 297 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.